NO865013L - Fremgangsmaate for fremstilling av antibakterielle kinolonderivater. - Google Patents

Fremgangsmaate for fremstilling av antibakterielle kinolonderivater.

Info

Publication number
NO865013L
NO865013L NO865013A NO865013A NO865013L NO 865013 L NO865013 L NO 865013L NO 865013 A NO865013 A NO 865013A NO 865013 A NO865013 A NO 865013A NO 865013 L NO865013 L NO 865013L
Authority
NO
Norway
Prior art keywords
quinolon
antibacterial
derivatives
procedure
preparation
Prior art date
Application number
NO865013A
Other languages
English (en)
Norwegian (no)
Other versions
NO865013D0 (no
Inventor
Ashok K Trehan
Joseph P Sanchez
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/808,122 external-priority patent/US4668680A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO865013D0 publication Critical patent/NO865013D0/no
Publication of NO865013L publication Critical patent/NO865013L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO865013A 1985-12-12 1986-12-11 Fremgangsmaate for fremstilling av antibakterielle kinolonderivater. NO865013L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/808,122 US4668680A (en) 1985-12-12 1985-12-12 5-amino-6,8-difluoroquinolones as antibacterial agents
US06/918,568 US4977154A (en) 1985-12-12 1986-10-20 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents

Publications (2)

Publication Number Publication Date
NO865013D0 NO865013D0 (no) 1986-12-11
NO865013L true NO865013L (no) 1987-06-15

Family

ID=27123084

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865013A NO865013L (no) 1985-12-12 1986-12-11 Fremgangsmaate for fremstilling av antibakterielle kinolonderivater.

Country Status (16)

Country Link
US (1) US4977154A (de)
EP (1) EP0226961B1 (de)
KR (1) KR900000555B1 (de)
CN (1) CN1013114B (de)
AU (1) AU591732B2 (de)
DE (1) DE3679793D1 (de)
DK (1) DK166493B1 (de)
ES (1) ES2039198T3 (de)
FI (1) FI865004A (de)
GR (1) GR3002129T3 (de)
HU (1) HU203231B (de)
IE (1) IE59261B1 (de)
IL (1) IL80933A (de)
NO (1) NO865013L (de)
OA (1) OA08561A (de)
PT (1) PT83909B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
EP0242789A3 (de) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Chinolinderivate und Verfahren zu ihrer Herstellung
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US4933335A (en) * 1987-08-07 1990-06-12 Warner-Lambert Company Quinolones as antibacterial agents
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
EP0339406A1 (de) * 1988-04-19 1989-11-02 Hokuriku Pharmaceutical Co.,Ltd Derivate der Chinolin-3-carbonsäure, Verfahren zu ihrer Herstellung und diese Derivate enthaltende antibakterielle Zusammensetzung
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
FI95130C (fi) * 1988-07-20 1995-12-27 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
JPH05506033A (ja) 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 抗微生物性キノロニルラクタム類
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
MX9700497A (es) * 1994-07-18 1997-04-30 Ube Industries Derivado de acido trifluorometilquinolinocarboxilico.
US5866150A (en) * 1996-03-20 1999-02-02 Aquaculture Technology Incorporated Antibacterially active extracts from the marine algae chaetoceros and methods of use
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
CN1091103C (zh) * 1999-04-02 2002-09-18 中国科学院上海药物研究所 一类喹诺酮类化合物及它的制备和其用途
US7176313B2 (en) * 2000-02-09 2007-02-13 Daiichi Pharmaceutical Co., Ltd. Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
DE102004035203A1 (de) * 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN100415212C (zh) * 2006-07-21 2008-09-03 哈药集团制药总厂 一种含乳酸卡德沙星的口服制剂
ES2809177T3 (es) 2008-10-07 2021-03-03 Horizon Orphan Llc Inhalación de levofloxacino para reducir la inflamación pulmonar
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
CA2773033C (en) 2009-09-04 2016-10-11 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis
CN104557896A (zh) * 2013-10-18 2015-04-29 沈敬山 布瑞哌唑、其关键中间体及其盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
EP0160578B1 (de) * 1984-02-17 1989-11-23 Daiichi Seiyaku Co., Ltd. 1,8-Naphthyridinderivate
US4604401A (en) * 1984-07-20 1986-08-05 Warner-Lambert Company Antibacterial agents III
JPS61205258A (ja) * 1985-03-08 1986-09-11 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体及びその製造方法
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof

Also Published As

Publication number Publication date
IE59261B1 (en) 1994-01-26
ES2039198T3 (es) 1993-09-16
EP0226961B1 (de) 1991-06-12
IL80933A0 (en) 1987-03-31
IL80933A (en) 1991-06-10
IE863104L (en) 1987-06-12
GR3002129T3 (en) 1992-12-30
EP0226961A1 (de) 1987-07-01
HUT42470A (en) 1987-07-28
CN1013114B (zh) 1991-07-10
AU591732B2 (en) 1989-12-14
KR870006034A (ko) 1987-07-08
PT83909A (en) 1987-01-01
DK590586A (da) 1987-06-13
AU6587986A (en) 1987-06-18
OA08561A (en) 1988-09-30
CN86108942A (zh) 1987-11-04
FI865004A0 (fi) 1986-12-08
PT83909B (pt) 1989-05-12
US4977154A (en) 1990-12-11
DE3679793D1 (de) 1991-07-18
DK590586D0 (da) 1986-12-09
FI865004A (fi) 1987-06-13
KR900000555B1 (ko) 1990-01-31
DK166493B1 (da) 1993-06-01
NO865013D0 (no) 1986-12-11
HU203231B (en) 1991-06-28

Similar Documents

Publication Publication Date Title
NO874764L (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO870579D0 (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO883722L (no) Fremgangsmaate for fremstilling av antibakterielle kinolon- og naftyridinderivater.
NO862661D0 (no) Fremgangsmaate for fremstilling av n-aralkylpiperidinmethanolderivater.
NO865013L (no) Fremgangsmaate for fremstilling av antibakterielle kinolonderivater.
NO862861L (no) Fremgangsmaate for fremstilling av distamycinderivater.
NO864110D0 (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO863251L (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO884900D0 (no) Fremgangsmaate for fremstilling av ginkolid-derivater.
NO861307L (no) Fremgangsmaate for fremstilling av cellulosemasse.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
NO864087D0 (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO862493L (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
NO842480L (no) Fremgangsmaate for fremsilling av antibakterielle 2-alkyltiopenem-derivater.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
NO874698L (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO873019D0 (no) Fremgangsmaate for fremstilling av tetrahydrobenzotiazolkinolin-derivater.
NO900651D0 (no) Fremgangsmaate for fremstilling av 2-benzyl-1-nafthol.